Good morning, everyone. Welcome to our committee. I'm very pleased to have you here today.
This meeting is pursuant to Standing Order 108(2), dealing with our study on neurological diseases.
Our witness from the Amyotrophic Lateral Sclerosis Society of Canada is David Cameron, the president and chief executive. Welcome, Mr. Cameron.
We also have Nigel Van Loan, a board member. Welcome, Nigel, I'm glad you're here.
We have François Gros-Louis, an assistant professor and a very astute researcher, I understand, with his own lab recently. Welcome, François.
We also have Sari Jormanainen. Welcome. I am so glad you are here this morning, Sari.
You will have ten minutes each for your presentations.
We will begin with Mr. Cameron, please.